Nancy Stuart

Insider Reports History

Entity
Individual
Location
99 Hayden Avenue, Suite 500, Lexington, MA
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy Stuart:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KalVista Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 10K Oct 3, 2024 Direct
CONCERT PHARMACEUTICALS, INC. Chief Operating Officer Common Stock 0 $8.33 Mar 6, 2023 Direct
CONCERT PHARMACEUTICALS, INC. Chief Operating Officer Performance Stock Units 0 Mar 6, 2023 Direct
CONCERT PHARMACEUTICALS, INC. Chief Operating Officer Stock Option (Right to Buy) 0 Mar 6, 2023 Direct

Insider Reports Filed by Nancy Stuart

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALV KalVista Pharmaceuticals, Inc. Oct 3, 2024 1 $0 4 Oct 4, 2024 Director
KALV KalVista Pharmaceuticals, Inc. Sep 26, 2023 1 $0 4 Sep 28, 2023 Director
CNCE CONCERT PHARMACEUTICALS, INC. Mar 6, 2023 10 $0 4 Mar 6, 2023 Chief Operating Officer
CNCE CONCERT PHARMACEUTICALS, INC. Feb 15, 2023 1 -$50.4K 4 Feb 16, 2023 Chief Operating Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 30, 2023 1 -$110K 4 Jan 31, 2023 Chief Operating Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 6, 2023 1 -$21K 4 Jan 9, 2023 Chief Operating Officer
KALV KalVista Pharmaceuticals, Inc. Oct 13, 2022 1 $0 4 Oct 17, 2022 Director
CNCE CONCERT PHARMACEUTICALS, INC. Feb 14, 2022 1 -$18.6K 4 Feb 16, 2022 Chief Operating Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 28, 2022 2 $0 4 Feb 1, 2022 Chief Operating Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 5, 2022 1 -$9.23K 4 Jan 7, 2022 Chief Operating Officer